Bruno Wohlschlegel
Chief Executive Officer at APONTIS PHARMA AG
Profile
Bruno Wohlschlegel is currently the Chief Executive Officer at APONTIS PHARMA AG and APONTIS PHARMA Deutschland GmbH & Co. KG.
Bruno Wohlschlegel active positions
| Companies | Position | Start |
|---|---|---|
| APONTIS PHARMA AG | Chief Executive Officer | - |
Apontis Pharma GmbH & Co. KG
 Apontis Pharma GmbH & Co. KG Pharmaceuticals: MajorHealth Technology APONTIS PHARMA Deutschland GmbH & Co. KG engages in the wholesale of pharmaceutical products. It focuses on medicines used for the treatment of chronic obstructive pulmonary diseases, hypertension, and cardiovascular diseases. The company was founded on February 13, 2015 and is headquartered in Monheim, Germany. | Chief Executive Officer | 2023-08-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| APONTIS PHARMA AG | Health Technology |
| Private companies | 1 |
|---|---|
Apontis Pharma GmbH & Co. KG
Apontis Pharma GmbH & Co. KG Pharmaceuticals: MajorHealth Technology APONTIS PHARMA Deutschland GmbH & Co. KG engages in the wholesale of pharmaceutical products. It focuses on medicines used for the treatment of chronic obstructive pulmonary diseases, hypertension, and cardiovascular diseases. The company was founded on February 13, 2015 and is headquartered in Monheim, Germany. | Health Technology |
- Stock Market
- Insiders
- Bruno Wohlschlegel
